WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5301 Infant (under 12 months) mortality rate: 622
GDP / capita (US$): 1'3901 Child (under 5 years) mortality rate: 962

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 6'817  6'643  6'472  6'306  6'144  4'865  3'788  2'721 
Births 248  245  241  237  232  190  161  130 
Surviving infants 232  229  225  220  216  175  147  117 
Pop. less than 5 years 1'094  1'069  1'045  1'020  998  806  685  517 
Pop. less than 15 years 2'853  2'785  2'718  2'653  2'594  2'151  1'751  1'263 
Female 15-49 years 1'685  1'642  1'600  1'559  1'517  1'162  845  597 

Number of reported case

(Click for retrospective incidence data for Togo)
Diphtheria
Japanese encephalitis
Measles 564  238  187  120  425  3'578  4'548  33'960 
Mumps
Pertussis 30  32  34  53  72  115  431  3'901 
Polio* 20  178 
Rubella 38  33  69  80  87 
Rubella (CRS)
Tetanus (neonatal) 26  20  28  28  17  33  42  217 
Tetanus (total) 26  20  28  28  17  107  436 
Yellow fever 12 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Togo)
Vaccine year result method % card seen                                                
BCG 2011  97  EPI   79  97  97  90  94  91  83  100 
DTP1 2011  94  EPI   79  94  94  95  97  93  66 
DTP3 2011  84  EPI   79  84  84  92  92  89  50  77 
HepB_BD         
HepB3 2011  84  EPI   79  84  84  92  92  89 
Hib3 2011  84  EPI   79  84  84  92  92  89 
JapEnc         
MCV 2011  72  EPI   79  72  72  85  84  84  43  65 
MCV2         
PCV1         
PCV3         
Pol3 2011  84  EPI   79  84  84  92  92  89  50  78 
Rota1         
Rota_last         
Rubella1         
TT2plus          78  78  86  85  82  47  35 
PAB         
VAD1          89  91  83  99* 
YFV 2011  72  EPI   79  72  72  85  84  84 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Togo)
BCG 97  97  97  97  91  84  99 
DTP1 94  94  94  97  93  80  90 
DTP3 84  84  85  83  78  64  77 
HepB3 84  84  85  83  78 
HepB_BD
Hib3 84  84  85  83  78 
MCV 72  72  72  68  66  58  73 
MCV2
PAB 77  81  81  81  81  63  47 
PCV3
Pol3 84  84  85  83  78  63  76 
Rota_last
YFV 72  72  72  67  64 

Number of districts in the country 40  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 38
From 80 to 89% 55
From 50 to 79% 8
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 0, +1, +6 months; No From November 2014
Measles 9 months; Yes
MenA 1-29 years; Yes From October 2014
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From April 2014
Rotavirus 6, 10 weeks; Yes From April 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 9 months; Yes and post-partum women
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011 - 2015  2011 - 2015  2007 - 2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 40  35  35  35  35  35  35 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 40  35  35  35  35  35  35 
Nº districts with DTP3 coverage >=80% number 37  33  30  31  29  30 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  94  86  89  83  86  20 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 10  20  23  20  26  14   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 42  25  25  10  15  97 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.